These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 25001244

  • 1. Central nervous system bleeding in pediatric patients with factor XIII deficiency: a study on 23 new cases.
    Naderi M, Alizadeh S, Kazemi A, Tabibian S, Zaker F, Bamedi T, Kashani Khatib Z, Dorgalaleh A.
    Hematology; 2015 Mar; 20(2):112-8. PubMed ID: 25001244
    [Abstract] [Full Text] [Related]

  • 2. Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.
    Naderi M, Dorgalaleh A, Alizadeh S, Tabibian S, Hosseini S, Shamsizadeh M, Bamedi T.
    Int J Hematol; 2014 Nov; 100(5):443-9. PubMed ID: 25230816
    [Abstract] [Full Text] [Related]

  • 3. First cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran.
    Hosseini S, Dorgalaleh A, Bamedi T, Tavakol K, Tabibian S, Naderi M, Alizadeh S, Varmaghani B, Shamsizadeh M, Rahimizadeh A, Ebrahimi S.
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):908-11. PubMed ID: 26226252
    [Abstract] [Full Text] [Related]

  • 4. Intracranial hemorrhage pattern in the patients with factor XIII deficiency.
    Naderi M, Zarei T, Haghpanah S, Eshghi P, Miri-Moghaddam E, Karimi M.
    Ann Hematol; 2014 Apr; 93(4):693-7. PubMed ID: 24149912
    [Abstract] [Full Text] [Related]

  • 5. Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.
    Katona É, Muszbek L, Devreese K, Kovács KB, Bereczky Z, Jonkers M, Shemirani AH, Mondelaers V, Ermens AA.
    Haemophilia; 2014 Jan; 20(1):114-20. PubMed ID: 24118344
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss.
    Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach M, Oberkanins C, Moritz A, Krugluger W, Huber J, Hopmeier P.
    Clin Chem; 2003 Jul; 49(7):1081-6. PubMed ID: 12816904
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of coagulation factor XIII and plasminogen activator inhibitor-1 gene polymorphisms among Egyptian women suffering from unexplained primary recurrent miscarriage.
    Elmahgoub IR, Afify RA, Abdel Aal AA, El-Sherbiny WS.
    J Reprod Immunol; 2014 Jun; 103():18-22. PubMed ID: 24702949
    [Abstract] [Full Text] [Related]

  • 8. Segmental uniparental disomy as a rare cause of congenital severe factor XIII deficiency in a girl with only one heterozygous carrier parent.
    Shen MC, Chen M, Chang SP, Lin PT, Hsieh HN, Lin KH.
    Pediatr Hematol Oncol; 2018 Jun; 35(7-8):442-446. PubMed ID: 30702381
    [Abstract] [Full Text] [Related]

  • 9. Association of TAFI gene polymorphisms with severity of coronary stenosis in stable coronary artery disease.
    Rattanawan C, Komanasin N, Settasatian N, Settasatian C, Kukongviriyapan U, Intharapetch P, Senthong V.
    Thromb Res; 2018 Nov; 171():171-176. PubMed ID: 30321704
    [Abstract] [Full Text] [Related]

  • 10. Expression and CpG island methylation pattern of MMP-2 and MMP-9 genes in patients with congenital factor XIII deficiency and intracranial hemorrhage.
    Noroozi-Aghideh A, Kashani Khatib Z, Naderi M, Dorgalaleh A, Yaghmaie M, Paryan M, Alizadeh S.
    Hematology; 2019 Dec; 24(1):601-605. PubMed ID: 31469059
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms of plasminogen activator inhibitor-1, angiotensin converting enzyme and coagulation factor XIII genes in patients with recurrent spontaneous abortion.
    Aarabi M, Memariani T, Arefi S, Aarabi M, Hantoosh Zadeh S, Akhondi MA, Modarressi MH.
    J Matern Fetal Neonatal Med; 2011 Mar; 24(3):545-8. PubMed ID: 20822334
    [Abstract] [Full Text] [Related]

  • 12. Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.
    Velickovic J, Jelicic M, Stojkovic O.
    Blood Coagul Fibrinolysis; 2021 Mar 01; 32(2):103-107. PubMed ID: 33555692
    [Abstract] [Full Text] [Related]

  • 13. Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency.
    Naderi M, Dorgalaleh A, Alizadeh S, Kashani Khatib Z, Tabibian S, Kazemi A, Dargahi H, Bamedi T.
    Haemophilia; 2014 Jan 01; 20(1):e89-92. PubMed ID: 24354489
    [No Abstract] [Full Text] [Related]

  • 14. Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system.
    Zorio E, Castelló R, Falcó C, España F, Osa A, Almenar L, Aznar J, Estellés A.
    Br J Haematol; 2003 Sep 01; 122(6):958-65. PubMed ID: 12956767
    [Abstract] [Full Text] [Related]

  • 15. Association between factor XIII single nucleotide polymorphisms and aneurysmal subarachnoid hemorrhage.
    Ladenvall C, Csajbok L, Nylén K, Jood K, Nellgård B, Jern C.
    J Neurosurg; 2009 Mar 01; 110(3):475-81. PubMed ID: 19061349
    [Abstract] [Full Text] [Related]

  • 16. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group.
    Br J Haematol; 2006 Dec 01; 135(5):697-702. PubMed ID: 17107352
    [Abstract] [Full Text] [Related]

  • 17. Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency.
    Jang MA, Park YS, Lee KO, Kim HJ.
    Blood Coagul Fibrinolysis; 2015 Jan 01; 26(1):46-9. PubMed ID: 25004025
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
    Ashley C, Chang E, Davis J, Mangione A, Frame V, Nugent DJ.
    Haemophilia; 2015 Jan 01; 21(1):102-8. PubMed ID: 25377187
    [Abstract] [Full Text] [Related]

  • 19. Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations.
    Borhany M, Handrkova H, Cairo A, Schroeder V, Fatima N, Naz A, Amanat S, Shamsi T, Peyvandi F, Kohler HP.
    Haemophilia; 2014 Jul 01; 20(4):568-74. PubMed ID: 24329762
    [Abstract] [Full Text] [Related]

  • 20. Novel Insights into Heterozygous Factor XIII Deficiency.
    Dorgalaleh A.
    Semin Thromb Hemost; 2024 Mar 01; 50(2):200-212. PubMed ID: 36940714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.